Sr Director Government Policy, Advocacy & Reimbursement EMEA at Baxter & Vice-chair of the Community Care Sector Group at MedTech Europe
Sandra is a Senior Public Affairs & Market Access professional with over 16 years of experience in working in European Government Affairs, Patient Advocacy & Market Access areas in the pharmaceutical & medical device industry.
Since Oct 2015 she is with Baxter where she is leading the Government Policy, Advocacy & Reimbursement for the EMEA Region. Prior to joining Baxter, Sandra headed up Hospira’s Government Affairs team in EMEA, and held various roles of increasing responsibility in EU Government Affairs for GSK, Novartis and Sandoz.
She has worked across a broad range of therapeutic areas in renal replacement & acute therapies, clinical nutrition, biosimilars, vaccines, diabetes, cardiovascular disease, & EU institutional and national government engagement, and increasingly health economic evidence and value creation.
1 blog from the author
Posted on 11.03.2021
Providing health services in the community offers benefits to patients and can be more efficient for health systems. This was true long before any of us had heard of COVID-19, but the pandemic has highlighted the need to provide safe and effective community and home care for vulnerable patients, like those suffering from chronic kidney […]